Oct 6, 2026 06:00AM
Oct 6, 2026 06:00AM
Sep 24, 2026 08:01AM
Sep 24, 2026 08:00AM
Sep 15, 2026 08:00AM
Sep 14, 2026 08:30AM
Sep 11, 2026 08:31AM Quantum BioPharma gets FDA clearance for MS drug phase 2 trial
Sep 11, 2026 08:30AM
Sep 11, 2026 08:30AM
Sep 10, 2026 08:30AM
Sep 9, 2026 08:32AM
Sep 9, 2026 08:30AM
Sep 8, 2026 08:30AM
Aug 14, 2026 07:00AM Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
Aug 14, 2026 07:00AM
Aug 10, 2026 07:00AM
Aug 10, 2026 07:00AM
Jun 24, 2026 08:30AM
Jun 22, 2026 08:30AM
May 18, 2026 05:08AM
May 18, 2026 03:00AM Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
May 7, 2026 07:02AM
May 7, 2026 07:00AM
Apr 1, 2026 08:04AM
Apr 1, 2026 08:02AM
Mar 26, 2026 08:00AM
Mar 26, 2026 08:00AM
Dec 23, 2025 08:02AM Quantum BioPharma completes dosing in toxicity studies for MS drug
Dec 23, 2025 08:00AM
Nov 7, 2025 07:00AM
Oct 23, 2025 08:15AM
Oct 2, 2025 07:57AM
Oct 2, 2025 07:57AM
Sep 29, 2025 07:44AM
Sep 29, 2025 07:40AM Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders
Aug 21, 2025 07:00AM
Aug 11, 2025 07:40AM
Aug 11, 2025 07:40AM
Aug 7, 2025 07:01AM
Aug 7, 2025 07:00AM
Aug 5, 2025 07:34AM
Aug 5, 2025 07:34AM Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid
Jun 18, 2025 09:19AM
May 20, 2025 07:31AM
May 20, 2025 07:30AM
May 12, 2025 08:04AM
May 12, 2025 08:00AM
Mar 28, 2025 09:16AM
Mar 28, 2025 09:15AM Quantum Biopharma's 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern
Mar 28, 2025 04:30AM

335,755 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All